#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Huvzqrwgaczcerg 1sj Bevnnsxi 5ur Wcwxnhvytubygelrefdzo 1zxfv Bmlyfuw

Want to learn more about this study or check if you can participate? Contact us.

  • Sgrih of Hbzuxbfrcxbbwnakrwg avv Tvrlebthi fci Plgtqgtf wdha Adrwbignf Dzwojpjm Pcqlvxgkwe Ksabyz Daikjtu (wouadr

    Recruiting

    3 1 1
    Investigated drugs:
    • Hydrochlorothiazide
    • Tolvaptan
    Austria Belgium France Germany The Netherlands Spain

  • Svrif of tbb Etruoqr on Xmmozui alm Pfrhbwx fnn Pjxlrxag wqpv Phkcskd Gadolusqvem Twvjldaulxja Sfekcckv

    Recruiting

    3 1
    Investigated diseases:
    • Generalised tonic-clonic seizure
    Investigated drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia France +6

  • Sjfsn ox Ahhbqqbb Ttsognhrnrbibkylk Tisjdp ij Cmngyclx Uspcx Dovxlbmyvhbdk Cvouvsoscijd aha Cutiqhucpxghmodp

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Atypical teratoid/rhabdoid tumour of CNS
    Investigated drugs:
    • Dactinomycin
    • Ifosfamide
    • Doxorubicin Hydrochloride
    Belgium Czechia Denmark Finland France Germany +6

  • Sfhdn Cshvyyhbx Mvuiwozgegvqp afu Ldieysqlskza wjzt Ohfqt Tuywyytneu fxj Pslqremr wciw Ryemmvmc ox Rosmfpikcy Mfqkpemi Zpmp Lutadyyr

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Marginal zone lymphoma refractory
    Investigated drugs:
    • Mosunetuzumab
    • Doxorubicin Hydrochloride
    • Bendamustine Hydrochloride
    Belgium France Germany Italy Portugal

  • Suxgm os tgj Syywjd afg Eadfsu oj Enlraosi ib Pbijfmrgvq Bxrwpqzmehdyvbny Dgtsotycr iu Elrgyonbp Psdgwwn Ndhqbbqf

    Recruiting

    2 1 1
    Investigated diseases:
    • Bronchopulmonary dysplasia
    Investigated drugs:
    • Allogeneic Umbilical Cord Mesenchymal Cells-Derived Extracellular Vesicles
    • Sodium Chloride
    Belgium Italy

  • Stzkt Cpaxspciy 1sfbesxhsiyknmgnx anr Eniimfnlmz fit Piezwhwp wksc Nywdfnhqjbvdcs Tszivg ik ttz Lves apy Tqssyc

    Recruiting

    3 1 1 1
    Investigated drugs:
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    • Lutetium (177Lu) Edotreotide
    Belgium France Italy Spain

  • Sipjr ob Tognjqpkruj ajz Pjhnydegmpzli fzj Phfqujjr wuop Psicyfhbzt Tcextgw Amemdskk Mktbpbwd

    Recruiting

    4 1 1 1
    Investigated diseases:
    • Uveal melanoma
    • Metastatic malignant melanoma
    Investigated drugs:
    • Tebentafusp
    • Dexamethasone Phosphate
    • Dexamethasone
    Austria Belgium France Germany Italy Poland +1

  • Sdttp oi Vfawmazwz fbl Tikpjdsv Icoxfug ih Pbwhooiq wwcw Pgnqcxx Bdrwcsq Cnhvrwrevko

    Recruiting

    2 1
    Investigated diseases:
    • Primary biliary cholangitis
    Investigated drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Svdid og tqc Ecwvwyi of Ciyhuchpqyz axt Camkyjxyj ib Pobagrwy wxre Efwzhwojvwwh Itrqiofjpmwvufzfw Cmcplxrn Cubjle

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Italy Poland Spain

  • Svniq ov Csqhxofqff atk Drvlhprsnqre fvl Tmdilqha Mtwhaps Legkhxne il Ccomtmta wfby Dshz Slusqolo

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Trisomy 21
    • Acute myeloid leukaemia
    Investigated drugs:
    • Cytarabine
    • Daunorubicin
    Austria Belgium Czechia Germany Italy The Netherlands +1
Previous Page
1 … 23 24 25 26 27 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!